[Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
The topical treatment of active chronic psoriasis can be achieved as effectively with 0,1% dithranol + 17% urea as with triamcinolone acetonite 0,1%. Compared with salicylic acid + dithranol preparations, the latter when combined with urea show a delayed clinical response, but less side effects. UVB in combination with the dithranol/urea preparation seems to be more efficient, without an increment of adverse effects. It would appear than an addition of urea offers an acceptable and effective alternative to salicylic acid.
D000293:Adolescent; D000328:Adult; D000873:Anthracenes / Q000627:therapeutic use*; D000875:Anthralin / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010789:Phototherapy; D011565:Psoriasis / Q000188:drug therapy*; D012459:Salicylates / Q000627:therapeutic use; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014508:Urea / Q000627:therapeutic use*
D000873:Anthracenes; D004338:Drug Combinations; D012459:Salicylates; D014508:Urea; D014222:Triamcinolone Acetonide; D000875:Anthralin
Dithranol-Harnstofftherapie bei Psoriasis vulgaris. Vergleichende Untersuchungen von Dithranol 0,1% + Harnstoff 17% mit Triamcinolonacetonid 0,1% und Phototherapie.